**Abstract**

It was reported that nitric oxide, acting as a neuromodulator and neurotransmitter in central nervous system, has proconvulsant or anticonvulsant activities in different experimental convulsion models. The aim of the present study was to investigate the role of nitric oxide pathway on the anticonvulsant activities of valproic acid, gabapentin and phenytoin and also agmatine suggested as an anticonvulsant agent.

Swiss albino mice were used for the study. Seizures were induced by single intraperitoneal injection of 45mg/kg penthylenetetrazole (PTZ). The existence of myoclonic jerk (MJ) and generalized tonic-clonic convulsions (GTCC) were recorded. Single doses of agmatine (10 mg/kg), valproic acid (150 mg/kg), gabapentin (20 mg/kg) and phenytoin (20 mg/kg) alone or with the precursor of nitric oxide, L-arginine (60 mg/kg) or non-specific nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) (5 mg/kg) were injected intraperitoneally.

Agmatine and valproic acid significantly prevented but phenytoin and gabapentin did not prevent the GTCC and MJ. L-arginine reduced the activity of agmatine on MJ but did not have any activity on GTCC. L-NAME did not affect the activity of agmatine on both MJ and GTCC. Both L-Arginine and L-NAME did not affect the activity of valproic acid and phenytoin on both MJ and GTCC. L-Arginine did not change the activity of gabapentin on both MJ and GTCC. L-NAME increased the activity of gabapentine on both MJ and GTCC.

This study suggested that nitric oxide may have a role on the anticonvulsant activity of agmatine and gabapentin but not those of valproic acid and phenytoin.
